EU Transdermal Patch: Generic Submission [Design Issues]

posted by HallaGulla – 2023-03-08 09:58 (836 d 07:50 ago) – Posting: # 23491
Views: 2,050
(edited on 2023-03-08 11:11)

Hi All

One of the clients with whom I am working is developing a generic transdermal patch for UK/EU submission.

They are asking us to do the PK study, Adhesion study and skin senstization study in either EU/UK or in USA due to simialr climatic condition.

My question is, can these studies be done in India or any other countries? Does MHRA/EMA accepts transdermal studies done in the geographies which has a different climatic conditions?


TIA...

Edit: Category changed; see also this post #1. Are you really located in Japan? ;-) [Helmut]

:lol: Shhhhh

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
59 visitors (0 registered, 59 guests [including 15 identified bots]).
Forum time: 18:48 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5